Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Potere Health MD vs Wisp

Potere Health MD
Graded #78

Lower grade

vs+2.799999999999997
Wisp
Graded #57

Higher grade

The verdict

Wisp takes it — 75.3/100 to 72.5/100.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePotere Health MD +1
85
84
Dose & formulationWisp +24
64
88
Clinical oversightPotere Health MD +5
87
82
Labs & monitoringPotere Health MD +1
54
53
FulfillmentPotere Health MD +1
67
66
Contract termsPotere Health MD +6
61
55
Potere Health MD · left barWisp · right bar

The numbers

MetricPotere Health MDWisp
WeighScore72.5/10075.3/100
GradeCC
Scorecard rank#78#57
Semaglutide$80/mo (starting dose, compounded)$225/mo (compounded oral)
Tirzepatide$135/mo (starting dose, compounded)$99/mo (starting dose, brand-name)
Coverage1 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Potere Health MD

Graded #78 · C

Strengths

  • Low starting pricing (about $80-$135/month) with no subscription lock-in
  • Physician-led by a named MD, not automated messaging
  • Third-party COA and LegitScript-certified pharmacy
  • Both telehealth and in-person Utah visits with fast scheduling

Where it loses points

  • Serves only patients located in Utah
  • Limited dose-specific pricing detail on main pages
  • Compounded medications are not FDA-approved
Wisp

Graded #57 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • Sublingual compounded semaglutide hasn't been tested in humans, per Wisp's own page — only the injectables have FDA efficacy data
  • Pharmacy partners not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard